Xtalks将举办免费网络研讨会解读ESMO 2026关键发现对癌症治疗与药物研发的影响
ESMO 2026: Key Findings for Cancer Care and Drug Development, Upcoming Webinar Hosted by Xtalks
Xtalks与Humaneva将于2026年11月9日上午11点（美东时间）举办免费网络研讨会，解读欧洲肿瘤内科学会（ESMO）2026年大会的关键临床研究结果与新兴疗法。Kapadi的Brandon Fletcher和Scott E. Smith博士将探讨这些发现对当前治疗决策、癌症治疗及肿瘤药物研发的意义，并分析尚存的不确定性与未来研究重点。
In this free webinar, learn how major findings from ESMO 2026 could influence cancer treatment and oncology drug development. The featured speakers will discuss key clinical trial results, emerging therapies and their relevance to current treatment decisions. Attendees will also explore remaining uncertainties, research gaps and priorities for future oncology development.
, /PRNewswire/ -- As oncology research continues to advance, understanding the clinical significance of emerging evidence is essential for informing treatment strategies and guiding future research. The European Society for Medical Oncology (ESMO) Congress 2026 brought together healthcare professionals, researchers and industry experts to examine the latest advances in cancer research, treatment and clinical practice.
This webinar will explore key clinical trial results and advances in cancer therapies presented at ESMO 2026, with a focus on their implications for cancer treatment and oncology drug development. By examining these findings alongside existing treatment approaches, the discussion will highlight opportunities to improve patient care and advance therapeutic development.
The featured speakers will place these findings in the context of current evidence, examining their relevance to treatment decisions, remaining uncertainties and priorities for further research. Participants will gain a concise overview of the key messages presented at the congress and their significance for cancer care and oncology development programs.
Register for this webinar by Humaneva to learn how key findings from ESMO 2026 may inform clinical decision-making, cancer treatment strategies and future oncology research.
Join experts from Kapadi, Brandon Fletcher, Head of Medical Affairs and Cell & Gene Therapy; and Scott E. Smith, MD, PhD, FACP, Chief Medical Officer, for the live webinar on Monday, November 9, 2026, at 11am EST (5pm CET / EU-Central).
For more information, or to register for this event, visit ESMO 2026: Key Findings for Cancer Care and Drug Development.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks
来源：PR Newswire — Trade Show News · prnewswire.com